#gene tac

1 story

#business #design therapeutics #dt-216p2 #friedreich ataxia #money #q1 2027 #q4 2026 #registrational update

Design Therapeutics DT-216P2 Registrational Update
Design Therapeutics plans registrational filing for DT-216P2 in Q4 2026 with 12-week results expected Q1 2027.
Seekingalpha · 1m